New oral therapy from Revolution Medicines earns FDA clearance for pancreatic cancer
TL;DR Summary
The FDA has approved Revolution Medicines' daily oral pill therapy to treat pancreatic cancer, marking a milestone in targeted, non-invasive cancer treatment based on recent clinical-trial results.
- FDA approves landmark pancreatic cancer drug that’s shown to improve survival AP News
- F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer The New York Times
- Revolution Medicines gets FDA nod for targeted pancreatic cancer drug CNN
- FDA Approves Drug for Pancreatic Cancer in Milestone for Treatment of Deadly Disease WSJ
- FDA approves first-of-a-kind pancreatic cancer drug trialed at Dana-Farber in Boston WCVB
Reading Insights
Total Reads
1
Unique Readers
2
Time Saved
24 min
vs 25 min read
Condensed
99%
4,873 → 27 words
Want the full story? Read the original article
Read on AP News